Biotech company specializing in MS and hemophilia drugs

biogen.com - biogen.com

Biogen Idec bio tech company is dedicated to developing new therapies to improve the lives of patients with neurological, autoimmune and hematological disorders

biogen.com pagerank   rank info for biogen.com 3,702,057   estimated valuation for biogen.com $ 240.00

Biotech company specializing in MS and hemophilia drugs

biogenidec.com - biogenidec.com

Biogen Idec bio tech company is dedicated to developing new therapies to improve the lives of patients with neurological, autoimmune and hematological disorders

biogenidec.com pagerank   rank info for biogenidec.com 205,608   estimated valuation for biogenidec.com $ 24,840.00

Patients Against Lymphoma - Lymphomation.org

lymphomation.org - lymphomation.org

Voicing patient perspectives and providing evidence-based education, support, and links to clinical trials specific to lymphoma.

lymphomation.org pagerank   rank info for lymphomation.org 710,326   estimated valuation for lymphomation.org $ 960.00

Platelet Disorder Support Association - for People with ITP - Platelet Disorder Support Association - for People with ITP

pdsa.org - pdsa.org

Platelet Disorder Support Association - For People with ITP. Comprehensive information and support for those concerned about ITP, immune thrombocytopenia.

pdsa.org pagerank   rank info for pdsa.org 1,258,168   estimated valuation for pdsa.org $ 480.00

Rituxan GPA & MPA Patient

rituxanforgpampa.com - rituxanforgpampa.com

Rituxan® (Rituximab) is indicated for the treatment of patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent, Previously untreated follicular, CD20-positive, B-cell NHL in combination with first-line chemotherapy and, in patients achieving a complete or partial...

rituxanforgpampa.com pagerank   rank info for rituxanforgpampa.com 10,467,497   estimated valuation for rituxanforgpampa.com $ 8.95

Inducing Remission in GPA & MPA Patients | Rituxan® GPA & MPA | HCP

rituxanforgpampa-hcp.com - rituxanforgpampa-hcp.com

Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis...

rituxanforgpampa-hcp.com pagerank   rank info for rituxanforgpampa-hcp.com 22,232,200   estimated valuation for rituxanforgpampa-hcp.com $ 8.95